Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1480-2026

EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5 Recall

EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5

FDA recall Class II

Ongoing

FDA lists this Class II recall for EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1480-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jan 21, 2026
FDA report date
Mar 11, 2026
Quantity in commerce
7
Distribution
See key details
FDA cause
Process control

What is being recalled?

EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5

Affected model & UDI checker

Search the exact identifiers published for Z-1480-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
VTICM5EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5Check source noticeNot specified
Not specifiedEVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5Check source notice00840311304363
FDA code information

UDI-DI: 00840311304363. Expiration Date: 2027-11-30 Serial Numbers: T2286964, T2286971, T2286973, T2286979, T2286980, T2286981, T2286988

View the original FDA recall notice

Why was this product recalled?

Toric Implantable Collamer for correction/reduction of myopia in phakic eyes with astigmatism were labeled as 12.1 mm length but are 12.6 mm length lenses, so there is the potential for excessive vault, which may cause: Significant reduction of irido-corneal angles, Significant shallowing of anterior chamber, Patient discomfort, Elevated IOP/Angle closure, Unreactive pupil, Lens exchange/removal.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Staar Surgical AG take?

On 1/21/2026, a Field Safety Notice was mailed to customers who were asked to do the following: 1. If any of the devices identified in the Field Safety Notice Return Response form have not already been implanted, remove them from your inventory and quarantine the product. 2. Complete the Field Safety Notice Return Response form indicating if each device has been implanted or is in your possession. 3. Complete and email the Field Safety Notice Return Response form to [email protected]. 5. Return affected devices to the firm. Should you have any questions, contact the firm's Representative or Customer Service at [email protected] or by phone at +41323328888 Monday through Friday, 8:00am to 5:00pm CET.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology